Robert W. Baird Issues Pessimistic Forecast for Intuitive Surgical (NASDAQ:ISRG) Stock Price

Intuitive Surgical (NASDAQ:ISRG) had its price objective decreased by equities researchers at Robert W. Baird from $600.00 to $536.00 in a research note issued to investors on Wednesday,MarketScreener reports. The brokerage presently has an “outperform” rating on the medical equipment provider’s stock. Robert W. Baird’s price target suggests a potential upside of 23.33% from the company’s current price.

Several other analysts have also recently issued reports on the stock. Wall Street Zen raised shares of Intuitive Surgical from a “hold” rating to a “buy” rating in a research report on Saturday, October 4th. Wells Fargo & Company increased their target price on shares of Intuitive Surgical from $559.00 to $599.00 and gave the stock an “overweight” rating in a report on Wednesday, July 23rd. UBS Group set a $529.00 price target on shares of Intuitive Surgical in a research report on Monday. Zacks Research lowered Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, August 20th. Finally, Royal Bank Of Canada reiterated an “outperform” rating and issued a $615.00 price objective on shares of Intuitive Surgical in a research note on Tuesday, August 19th. Fourteen investment analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $580.29.

Intuitive Surgical Stock Down 0.2%

ISRG opened at $434.62 on Wednesday. Intuitive Surgical has a 52 week low of $425.00 and a 52 week high of $616.00. The business has a fifty day simple moving average of $455.44 and a 200-day simple moving average of $496.18. The firm has a market cap of $155.80 billion, a P/E ratio of 60.62, a P/E/G ratio of 4.57 and a beta of 1.61.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings data on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.93 by $0.26. Intuitive Surgical had a return on equity of 14.56% and a net margin of 28.51%.The firm had revenue of $2.44 billion for the quarter, compared to the consensus estimate of $2.35 billion. During the same quarter in the previous year, the business earned $1.78 EPS. The company’s quarterly revenue was up 21.4% compared to the same quarter last year. Sell-side analysts expect that Intuitive Surgical will post 6.43 earnings per share for the current year.

Insider Activity at Intuitive Surgical

In other news, EVP Myriam Curet sold 4,500 shares of the stock in a transaction dated Friday, July 25th. The stock was sold at an average price of $492.48, for a total value of $2,216,160.00. Following the transaction, the executive vice president owned 353 shares in the company, valued at approximately $173,845.44. This represents a 92.73% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Amy L. Ladd sold 336 shares of the firm’s stock in a transaction dated Wednesday, September 3rd. The stock was sold at an average price of $470.11, for a total value of $157,956.96. Following the sale, the director directly owned 1,074 shares in the company, valued at $504,898.14. This trade represents a 23.83% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 45,224 shares of company stock valued at $21,716,492 over the last quarter. 0.70% of the stock is owned by insiders.

Institutional Trading of Intuitive Surgical

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in ISRG. 180 Wealth Advisors LLC lifted its position in shares of Intuitive Surgical by 14.5% during the 3rd quarter. 180 Wealth Advisors LLC now owns 4,145 shares of the medical equipment provider’s stock worth $1,854,000 after buying an additional 525 shares during the last quarter. Fulton Breakefield Broenniman LLC lifted its position in Intuitive Surgical by 4.9% in the third quarter. Fulton Breakefield Broenniman LLC now owns 1,403 shares of the medical equipment provider’s stock valued at $628,000 after acquiring an additional 65 shares during the last quarter. New Hampshire Trust boosted its stake in Intuitive Surgical by 3.1% in the third quarter. New Hampshire Trust now owns 821 shares of the medical equipment provider’s stock valued at $367,000 after acquiring an additional 25 shares in the last quarter. Emprise Bank purchased a new position in shares of Intuitive Surgical during the third quarter worth about $292,000. Finally, Tower View Wealth Management LLC grew its holdings in shares of Intuitive Surgical by 3.4% during the third quarter. Tower View Wealth Management LLC now owns 5,816 shares of the medical equipment provider’s stock worth $2,601,000 after purchasing an additional 192 shares during the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.